212Pb-Pretargeted Theranostics for Pancreatic Cancer

Overview of attention for article published in Journal of Nuclear Medicine, November 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 36 X users
patent: 1 patent

wikipedia: 1 Wikipedia page

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 39 X posts from 36 X users, with an upper bound of 60,255 followers.

RT @LewisLabMSKCC: Its out! First of 2024. 212Pb-Pretargeted Theranostics for Pancreatic Cancer. https://t.co/Q97KbWHTVK

Don't get excited. Mice.

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 35 additional X posts.